Skip to main content
Clinical Trials/NCT02243254
NCT02243254
Completed
Not Applicable

Prevention of Remifentanil-induced Postoperative Hyperalgesia With Intravenous Ibuprofen

Seoul National University Hospital1 site in 1 country120 target enrollmentJuly 2014

Overview

Phase
Not Applicable
Intervention
high dose remifentanil
Conditions
Ibuprofen
Sponsor
Seoul National University Hospital
Enrollment
120
Locations
1
Primary Endpoint
cumulative morphine consumption
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Postoperative hyperalgesia has been reported after intraoperative administration of small or high-dose remifentanil. Cyclooxygenase inhibitor exhibit preventive effects on the development of opioid-induced hyperalgesia. The aim of this study is to evaluate the preventive effect of intravenous ibuprofen (Caldolor®) on remifentanil-induced hyperalgesia

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
April 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients scheduled for elective pancreaticoduodenectomy

Exclusion Criteria

  • Patients with chronic pain
  • Patients with psychiatric disease
  • Patients with nonsteroidal antiinflammatory drugs allergy
  • Patients with renail dysfunction
  • History of drug addiction
  • Pregnant patient
  • Inability to use a PCA device

Arms & Interventions

high dose remifentanil without ibuprofen

remifentanil target-controlled infusion effect-site concentration 4 ng/ml normal saline before surgical incision

Intervention: high dose remifentanil

low dose remifentanil without ibuprofen

remifentanil target-controlled infusion effect-site concentration 1 ng/ml normal saline before surgical incision

Intervention: low dose remifentanil

high dose remifentanil with ibuprofen

remifentanil target-controlled infusion effect-site concentration 4 ng/ml Intravenous ibuprofen 800 mg before surgical incision

Intervention: high dose remifentanil

high dose remifentanil with ibuprofen

remifentanil target-controlled infusion effect-site concentration 4 ng/ml Intravenous ibuprofen 800 mg before surgical incision

Intervention: Ibuprofen

low dose remifentanil with ibuprofen

remifentanil target-controlled infusion effect-site concentration 1 ng/ml Intravenous ibuprofen 800 mg before surgical incision

Intervention: Ibuprofen

low dose remifentanil with ibuprofen

remifentanil target-controlled infusion effect-site concentration 1 ng/ml Intravenous ibuprofen 800 mg before surgical incision

Intervention: low dose remifentanil

Outcomes

Primary Outcomes

cumulative morphine consumption

Time Frame: postoperative 48 hours

cumulative patient-controlled analgesia (PCA) morphine consumption

Secondary Outcomes

  • Pain score(postoperative 1, 3, 6,12, 24, 48 hours Pain score)

Study Sites (1)

Loading locations...

Similar Trials